Unraveling the function of TSC1-TSC2 complex: implications for stem cell fate
Abstract Background Tuberous sclerosis complex is a genetic disorder caused by mutations in the TSC1 or TSC2 genes, affecting multiple systems. These genes produce proteins that regulate mTORC1 activity, essential for cell function and metabolism. While mTOR inhibitors have advanced treatment, maint...
Saved in:
Main Authors: | Shuang Wang, Ruishuang Ma, Chong Gao, Yu-Nong Tian, Rong-Gui Hu, Han Zhang, Lan Li, Yue Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-025-04170-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case Report: Rare cardiovascular characteristics of tuberous sclerosis complex with novel TSC2 variant
by: Zhiqin Du, et al.
Published: (2025-01-01) -
Animal amino acid sensor — A review
by: Yongding Ke, et al.
Published: (2025-02-01) -
Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months of age (PROTECT), a two-arm, randomized, observer-blind, controlled phase IIb national multicentre clinical trial: study protocol
by: Jan H. Driedger, et al.
Published: (2025-01-01) -
Fetal and neonatal cardiac tumor diagnosed as Tuberous Sclerosis associated rhabdomyomas resulting from novel pathogenic missense variant detected in TSC2 gene: A case report
by: Aya Kawasaki, MD, et al.
Published: (2025-03-01) -
Left ventricular hypertrophy in young hypertensives: the possible crosstalk of mTOR and angiotensin-II -a case-control study
by: Busayo Onafowoke Oguntola, et al.
Published: (2025-01-01)